Holen Sie sich die Stockscreener-App
12.81
4.97%
-0.67
Handel nachbörslich:
12.57
-0.24
-1.87%
Schlusskurs vom Vortag:
$13.48
Offen:
$13.23
24-Stunden-Volumen:
156.91K
Relative Volume:
0.50
Marktkapitalisierung:
$670.59M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-9.47%
1M Leistung:
+198.60%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$11.48
$13.85
1-Wochen-Bereich:
$6.44
$14.30
52-Wochen-Spanne:
$3.50
$14.30
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Company Profile
Vergleichen Sie ZYBT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZYBT
Zhengye Biotechnology Holding Ltd
|
12.81 | 670.59M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
158.06 | 68.50B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.38 | 47.71B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.63 | 46.12B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.39 | 18.55B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
298.70 | 13.40B | 2.76B | 1.11B | 898.10M | 22.77 |
Zhengye Biotechnology Holding Ltd Aktie (ZYBT) Neueste Nachrichten
Why Meta Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket - Benzinga
Zhengye Biotechnology Holding Ltd Inc. (ZYBT) Price Performance: A Technical Analysis Perspective - investchronicle.com
Zhengye Biotechnology Delays 20-F Filing - TipRanks
Zhengye Biotechnology Holding Ltd (ZYBT) Surges 35% - Energy & Capital
Zhengye Biotechnology Holding Ltd (ZYBT): Why Shares Soared 34.91% in a Single Day - Energy & Capital
Understanding ZYBT stock ratios for better investment decisions - uspostnews.com
Navigating ZYBT Stock: Zhengye Biotechnology Holding Ltd Journey - investchronicle.com
A Closer Look At Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) Uninspiring ROE - simplywall.st
Should We Be Cautious About Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) ROE Of 6.9%? - Yahoo Finance
Zhengye Biotechnology Forms Joint Venture to Expand Poultry Vaccine Sales - TipRanks
Nvidia, Tesla Slide Among Mega-Cap Movers on Wednesday By Investing.com - Investing.com Canada
Pre-market Movers: OSRH, SURG, BLNE, HUMA, TNON… - RTTNews
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Kuke Music Holding Ltd ADR’s: Contrasting Stock Performances in a Volatile Market - investchronicle.com
Trump Vs. OPEC Round 2: The Great Oil Showdown of 2025 - Energy & Capital
3 E Network Technology Group Ltd’s Quiet Period Will End on February 17th (NASDAQ:MASK) - Defense World
Zhengye Biotechnology Holding Limited’s (NASDAQ:ZYBT) Quiet Period Set To Expire on February 17th - Defense World
Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising - Bamboo Works
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters’ Over-Allotment Option - GlobeNewswire
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option - The Manila Times
Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering - GlobeNewswire
ZYBT Stock Price and Chart — NASDAQ:ZYBT - TradingView
ZYBT IPO NewsChinese animal health company Zhengye Biotechnology prices US IPO at the $4 low end - Renaissance Capital
Chinese vaccine maker Zhengye Biotechnology prices IPO at $4 per share - MSN
Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering - GlobeNewswire
Zhengye Biotechnology Holding Limited (ZYBT) to Raise $7 Million in IPO - Defense World
ZYBT News Today | Why did Zhengye Biotechnology stock go down today? - MarketBeat
Chinese animal health company Zhengye Biotechnology ups share offering by 20% ahead of $7 million US IPO - renaissancecapital.com
Gold Mining Stocks ListUnearthing Opportunities in 2024 - Energy & Capital
Why Does Elon's New Lithium Refinery Reek of the CCP? - Energy & Capital
InvestorsHubNYSE, NASDAQ, AMEX, OTCBB, Pink Sheet Stock Message Boards, Stock Charts, Stock Quotes, Level II and Market News - Investors Hub
Finanzdaten der Zhengye Biotechnology Holding Ltd-Aktie (ZYBT)
Es liegen keine Finanzdaten für Zhengye Biotechnology Holding Ltd (ZYBT) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.20%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):